A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells

Peptides

Volumn 31, Issue 8, 2010, Pages 1546-1554

  Koumbadinga, Gérémy Abdull ^a   Bawolak, Marie Thérèse ^a   Marceau, Emilie ^a   Adam, Albert ^b   Gerac, Lajos ^c   Marceaua, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Angiotensin converting enzyme; Bradykinin; Enalaprilat; Endothelial cells; Regulation of expression

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; ETANERCEPT; GLUCOSE; INSULIN; KININASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING ASSAY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL VEIN; UPREGULATION;

EID: 78249275188     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.04.027     Document Type: Article

References (36)

1. Adam A, Leclair P, Montpas N, Koumbadinga GA, Bachelard H, Marceau F. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin converting enzyme and other peptidases. Neuropeptides 2010; 44:69-75.
2. Bawolak MT, Fortin S, Bouthillier J, Adam A, Gera L, C-Gaudreault R, et al. Effects of inactivation-resistant agonists on the signaling, desensitization and downregulation of bradykinin B2 receptors. Br J Pharmacol 2009; 158:1375-1386
3. 8]-bradykinin): pharmacologic profile and effective induction of receptor downregulation. J Pharmacol Exp Ther 2007; 323:534-546
4. Bunning P, Holmquist B, Riordan JF. Substrate specificity and kinetic characteristics of angiotensin converting enzyme. Biochemistry 1983; 22:103-110
5. Chattopadhyay S, Santhamma KR, Sengupta S, McCue B, Kinter M, Sen GC, et al. Calmodulin binds to the cytoplasmic domain of angiotensin-converting enzyme and regulates its phosphorylation and cleavage secretion. J Biol Chem 2005; 280:33847-33855
6. 50) of an enzymatic reaction. Biochem Pharmacol 1973; 22:3099-3108
7. 9-bradykinin metabolic pathways and kinetics of activation of human plasma. Am J Physiol Heart Circ Physiol 2001; 281:H275-83.
8. Erdös EG, Skidgel RA. Metabolism of bradykinin by peptidases in health and disease. In: Farmer SG, editor. The kinin system. San Diego, CA: Academic Press; 1997. p. 111-141
9. Eyries M, Agrapart M, Alonso A, Soubrier F. Phorbol ester induction of angiotensin-concerting enzyme transcription is mediated by Egr-1 and AP-1 in human endothelial cells via ERK1/2 pathway. Circ Res 2002; 91:899-906.
10. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res 2006; 98:887-896
11. Fortin JP, Gera L, Bouthillier J, Stewart JM, Adam A, Marceau F. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. J Pharmacol Exp Ther 2005; 314:1169-1176
12. Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ. Effect of bradykininreceptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Engl J Med 1998; 339:1285-1292
13. Glauser DA, Schlegel W. Sequential actions of ERK1/2 on the AP-1 transcription factor allow temporal integration of metabolic signals in pancreatic β cells. FASEB J 2007; 21:3240-3249
14. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 1997; 80:383-392
15. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald 3rd JH, Neel DA, et al. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro- 4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13] oxadiazacyclohexadecene- 1,3(2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase Cβ. J Med Chem 1996; 39:2664-2671
16. Khamaisi M, Dahan R, Hamed S, Abassi Z, Heyman SN, Raz I. Role of protein kinase C in the expression of endothelin converting enzyme-1. Endocrinology 2009; 150:1440-1449
17. Kohlstedt K, Kellner R, Busse R, Fleming I. Signaling via the angiotensinconverting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA. Mol Pharmacol 2006; 69:19-26.
18. Konopatskaya O, Poole AW. Protein kinase Cα: disease regulator and therapeutic target. Trends Pharmacol Sci 2010; 31:8-14.
19. Leeb-Lundberg LM, Marceau F, Müller-Esterl W, Pettibone DJ, Zuraw BL. International Union of Pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57:27-77.
20. Marceau F, Grassi J, Frobert Y, Bergeron C, Poubelle PE. Effects of experimental conditions on the production of interleukin-1αand- 1βbyhumanendothelial cells cultured in vitro. Int J Immunopharmacol 1992; 14:525-534
21. Marceau F, Tremblay B, Couture R, Regoli D. Prostacyclin release induced by neurokinins in cultured human endothelial cells. Can J Physiol Pharmacol 1989; 67(159):162.
22. Moreau ME, Bawolak MT, Morissette G, Adam A, Marceau F. Role of nuclear factor-kB and protein kinase C signaling in the expression of the kinin B1 receptor in human vascular smooth muscle cells. Mol Pharmacol 2007; 71: 949-956
23. Morissette G, Couture JP, Désormeaux A, Adam A, Marceau F. Lack of direct interaction between enalaprilat and the kinin B1 receptors. Peptides 2008; 29:606-612
24. Naruse K, Rask-Madsen C, Takahara N, Ha SW, Suzuma K, Way KJ, et al. Activation of vascular protein kinase C-β inhibits Akt-dependent endothelial nitric oxide synthase function in obesity-associated insulin resistance. Diabetes 2006; 55:691-698
25. Papapetropoulos A, Antonov A, Virmani R, Kolodgie FD, Munn DH, Marczin N, et al. Monocyte- and cytokine-induced downregulation of angiotensinconverting enzyme in cultured human and porcine endothelial cells. Circ Res 1996; 79:512-523
26. Pretorius M, Rosenbaum D, Vaughan DE, Brown NJ. Angiotensin converting enzyme inhibition increases human vascular-type plasminogen activator release through endogenous bradykinin. Circulation 2003; 107: 579-585
27. Ramchandran R, Kasturi S, Douglas JG, Sen I. Metalloprotease-mediated cleavage secretion of pulmonary ACE by vascular endothelial and kidney epithelial cells. Am J Physiol Heart Circ Physiol 1996; 271:H744-51.
28. Saijonmaa O, Fyhrquist F. Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells. Cardiovasc Res 1998; 40:206-210
29. Saijonmaa O, Nyman T, Fyhrquist F. Downregulation of angiotensin- converting enzyme by tumor necrosis factor-α and interleukin-1β in cultured human endothelial cells. J Vasc Res 2001; 38:370-378
30. Saijonmaa O, Nyman T, Kosonen R, Fyhrquist F. Upregulation of angiotensinconverting enzyme by vascular endothelial growth factor. Am J Physiol Heart Circ Physiol 2001; 280:H885-91.
31. Sibony M, Gasc JM, Soubrier F, Alhenc-Gelas F, Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993; 21:827-835
32. Sibony M, Segretain D, Gasc JM. Angiotensin-converting enzyme in murine testis: step-specific expression of the germinal isoform during spermiogenesis. Biol Reprod 1994; 50:1015-1026
33. Squire IB, O'Kane KP, Anderson N, Reid JL. Bradykinin B2 receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 2000; 36:132-136
34. Strnad J, Burke JR. IκB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges. Trends Pharmacol Sci 2007; 28:142-148
35. Villard E, Alonso A, Agrapart M, Challah M, Soubrier F. Induction of angiotensin I-converting enzyme transcription by a protein kinase C-dependent mechanism in human endothelial cells. J Biol Chem 1998; 273:25191-25197
36. Yang J, Matsukawa N, Rakugi H, Imai M, Kida I, Nagai M, et al. Upregulation of cAMP is anewfunctional signal pathway of Klotho in endothelial cells. Biochem Biophys Res Commun 2003; 301:424-429